TD Private Client Wealth LLC Grows Holdings in Integer Holdings Co. (NYSE:ITGR)

TD Private Client Wealth LLC lifted its position in shares of Integer Holdings Co. (NYSE:ITGR) by 15.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,420 shares of the medical equipment provider’s stock after acquiring an additional 191 shares during the period. TD Private Client Wealth LLC’s holdings in Integer were worth $185,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in ITGR. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Integer during the 2nd quarter valued at approximately $247,000. Envestnet Portfolio Solutions Inc. raised its position in shares of Integer by 3.6% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock valued at $689,000 after acquiring an additional 205 shares in the last quarter. Raymond James & Associates increased its position in Integer by 5.7% in the second quarter. Raymond James & Associates now owns 52,496 shares of the medical equipment provider’s stock worth $6,079,000 after buying an additional 2,848 shares during the period. Louisiana State Employees Retirement System lifted its stake in Integer by 2.4% in the second quarter. Louisiana State Employees Retirement System now owns 16,900 shares of the medical equipment provider’s stock valued at $1,957,000 after buying an additional 400 shares during the last quarter. Finally, Tributary Capital Management LLC boosted its holdings in shares of Integer by 0.3% during the second quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after acquiring an additional 772 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Trading Down 0.4 %

NYSE:ITGR opened at $138.71 on Monday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. Integer Holdings Co. has a 1-year low of $94.56 and a 1-year high of $142.76. The firm has a market capitalization of $4.65 billion, a price-to-earnings ratio of 42.81, a price-to-earnings-growth ratio of 2.02 and a beta of 1.12. The stock has a fifty day simple moving average of $133.78 and a 200 day simple moving average of $125.78.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. During the same quarter last year, the company posted $1.27 EPS. Integer’s revenue for the quarter was up 8.7% on a year-over-year basis. Sell-side analysts forecast that Integer Holdings Co. will post 5.33 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ITGR. Wells Fargo & Company reiterated an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research report on Tuesday, December 3rd. Bank of America lifted their price target on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Benchmark increased their price objective on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. Citigroup lifted their target price on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Finally, Piper Sandler reissued an “overweight” rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $145.44.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.